Scynexis Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +24.2% | +21.3% | -23.3% | +16.0% | +7.5% | +79.4% | +16.9% | -26.7% | +46.2% | -29.4% | -34.9% | |
| – | +22.2% | +22.5% | -24.2% | +14.5% | +1.8% | +87.4% | +11.4% | -27.7% | +29.2% | -29.3% | -44.1% | |
| – | +45.7% | -24.1% | -67.8% | -0.3% | +266.5% | +121.9% | +12.3% | -56.2% | -25.7% | -52.9% | +32.4% | |
| – | +45.7% | +24.7% | -25.1% | +0.6% | +9.6% | +92.2% | +12.3% | -29.7% | +1.2% | -20.3% | -64.2% | |
| – | +311.5% | -74.9% | +7.7% | +2,582.1% | – | – | -70.1% | +144.0% | +938.8% | -53.0% | – | |
| – | -93.3% | -3.5% | +55.2% | -28.3% | – | – | -75.8% | +94.2% | -100.0% | – | – | |
| – | -100.0% | – | – | +12,800.0% | -21.5% | +714.1% | -96.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -61.4% | – | – | – | |
| – | +17.4% | +241.0% | -2.1% | -10.2% | +101.7% | +80.3% | -1.5% | +7.6% | -34.4% | -35.9% | -72.9% | |
| – | +24.6% | -44.2% | +172.9% | -42.1% | +87.4% | +139.7% | -48.4% | +29.4% | -7.5% | +47.8% | -76.2% | |
| – | – | – | -69.5% | – | – | +44.4% | +34.6% | +302.9% | +20.6% | +4,045.6% | -96.6% | |
| – | +45.3% | +254.1% | +74.9% | -4.7% | +96.5% | -35.4% | +69.2% | -24.4% | +20.4% | -36.1% | -51.3% | |
| – | – | – | -27.7% | +46.4% | -23.6% | +43.3% | +74.0% | +57.9% | -73.2% | – | – | |
| – | +25.5% | -17.0% | -38.5% | +45.8% | -58.7% | +76.5% | +81.3% | -92.2% | +2,156.8% | -24.5% | -10.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +104.9% | +1,152.0% | -82.4% | +64.1% | +27.8% | +91.2% | +146.1% | +61.5% | +13.6% | +0.3% | +2.9% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.